Cytokine gene polymorphisms and the outcome of invasive candidiasis: A prospective cohort study

Clinical Infectious Diseases

Volumn 54, Issue 4, 2012, Pages 502-510

  Johnson, Melissa D ^a,b   Plantinga, Theo S ^c   Van De Vosse, Esther ^e   Velez Edwards, Digna R ^f   Smith, P Brian ^a   Alexander, Barbara D ^a   Yang, John C ^g   Kremer, Dennis ^e   Laird, Gregory M ^a   Oosting, Marije ^c   Joosten, Leo A B ^c   Van Der Meer, Jos W M ^c   Van Dissel, Jaap T ^e   Walsh, Thomas J ^h   Perfect, John R ^a   Kullberg, Bart Jan ^c   Scott, William K ^d   Netea, Mihai G ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CAMPBELL UNIVERSITY   (United States)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^g DEPARTMENT OF MEDICINE   (United States)

^h Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 8;

ADULT; ARTICLE; CANDIDEMIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIALYSIS; FEMALE; GENOTYPE; HUMAN; IN VITRO STUDY; INFECTION SENSITIVITY; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; TOTAL PARENTERAL NUTRITION;

ADULT; AGED; CANDIDIASIS, INVASIVE; CELLS, CULTURED; COHORT STUDIES; CYTOKINES; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84863039528     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir827     Document Type: Article

References (30)

1. Garey KW, Rege M, Pai MP, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multiinstitutional study. Clin Infect Dis 2006; 43:25-31. (Pubitemid 43939072)
2. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4:1-23.
3. Netea MG, Brown GD, Kullberg BJ, Gow NA. An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 2008; 6:67-78. (Pubitemid 350286221)
4. Ashman RB, Farah CS, Wanasaengsakul S, Hu Y, Pang G, Clancy RL. Innate versus adaptive immunity in Candida albicans infection. Immunol Cell Biol 2004; 82:196-204. (Pubitemid 38594652)
5. Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 1999; 2:363-7. (Pubitemid 29366956)
6. Tuite A, Mullick A, Gros P. Genetic analysis of innate immunity in resistance to Candida albicans. Genes Immun 2004; 5:576-87. (Pubitemid 39529975)
7. Sørensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318:727-32. (Pubitemid 18090256)
8. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol 2008; 10:2058-66.
9. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-75. (Pubitemid 47330214)
10. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29:311-22.
11. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-9. (Pubitemid 34680308)
12. Ferwerda B, Ferwerda G, Plantinga TS, et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361:1760-7.
13. Bochud PY, Chien JW, Marr KA, et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl JMed 2008; 359:1766-77.
14. Van der Graaf CA, Netea MG, Morré SA, et al. Toll-like receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 2006; 17:29-34.
15. Woehrle T, Du W, Goetz A, et al. Pathogen specific cytokine release reveals an effect of TLR2 Arg753Gln during Candida sepsis in humans. Cytokine 2008; 41:322-9.
16. Murray HW. Interferon-gamma in infection and immunoparalysis. Intensive Care Med 1996; 22(Suppl 4):S455. (Pubitemid 26370895)
17. Puccetti P, Romani L, Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3:237-40.
18. Romani L, Mencacci A, Grohmann U, et al. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992; 176: 19-25.
19. Romani L, Puccetti P, Mencacci A, et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994; 152: 3514-21. (Pubitemid 24098048)
20. Morahan G, Huang D, Wu M, et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 2002; 360:455-9. (Pubitemid 34880144)
21. Müller-Berghaus J, Kern K, Paschen A, et al. Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun 2004; 5:431-4. (Pubitemid 39139772)
22. Zeng L, Gu W, Chen K, et al. Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care 2009; 13:R188.
23. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24:1-8. (Pubitemid 27050850)
24. Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 2006; 32:260-6. (Pubitemid 43251147)
25. Schaaf BM, Boehmke F, Esnaashari H, et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 2003; 168:476-80. (Pubitemid 37046878)
26. Hunninghake GM, Soto-Quirós ME, Lasky-Su J, et al. Dust mite exposure modifies the effect of functional IL10 polymorphisms on allergy and asthma exacerbations. J Allergy Clin Immunol 2008; 122:93-8.
27. Roilides E, Sein T, Roden M, Schaufele RL, Walsh TJ. Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis. J Infect Dis 2001; 183:518-20. (Pubitemid 32105614)
28. Bodasing N, Seaton RA, Shankland GS, Pithie A. Gamma-interferon treatment for resistant oropharyngeal candidiasis in an HIV-positive patient. J Antimicrob Chemother 2002; 50:765-6. (Pubitemid 35331704)
29. Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ES. Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Antimicrob Agents Chemother 2008; 52:716-8. (Pubitemid 351170848)
30. Kovacicova G, Lovaszova M, Hanzen J, et al. Persistent fungemia-risk factors and outcome in 40 episodes. J Chemother 2001; 13:429-33. (Pubitemid 32721637)